153 related articles for article (PubMed ID: 28343298)
1. Thiazide increases serum calcium in anuric patients: the role of parathyroid hormone.
Vasco RFV; Reis ET; Moyses RMA; Elias RM
Arch Osteoporos; 2017 Dec; 12(1):31. PubMed ID: 28343298
[TBL] [Abstract][Full Text] [Related]
2. Thiazide diuretics do not potentiate cAMP response to parathyroid hormone.
Marcus R; Orner F; Arvesen G; Lundquist C
Metabolism; 1978 Jun; 27(6):701-10. PubMed ID: 206800
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid Hormone and the Use of Diuretics and Calcium-Channel Blockers: The Multi-Ethnic Study of Atherosclerosis.
Zaheer S; de Boer I; Allison M; Brown JM; Psaty BM; Robinson-Cohen C; Ix JH; Kestenbaum B; Siscovick D; Vaidya A
J Bone Miner Res; 2016 Jun; 31(6):1137-45. PubMed ID: 26748479
[TBL] [Abstract][Full Text] [Related]
6. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels.
Sigurdsson G; Franzson L
J Intern Med; 2001 Jul; 250(1):51-6. PubMed ID: 11454142
[TBL] [Abstract][Full Text] [Related]
7. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women.
Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
Eur J Clin Invest; 2001 Sep; 31(9):764-72. PubMed ID: 11589718
[TBL] [Abstract][Full Text] [Related]
8. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
9. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Elias RM; Moysés RMA
Int Urol Nephrol; 2017 Oct; 49(10):1815-1821. PubMed ID: 28695313
[TBL] [Abstract][Full Text] [Related]
10. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
11. [Effects of thiazide diuretics on the regulation mechanisms of calcium and phosphorus metabolism].
Mazzuoli GF; D'Erasmo E; Scarda A; Mancini D; Malaguti Aliberti L; Minisola S; Lo Schiavo P
Minerva Nefrol; 1979; 26(4):549-52. PubMed ID: 542225
[No Abstract] [Full Text] [Related]
12. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
[TBL] [Abstract][Full Text] [Related]
13. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
Slatopolsky EA; Burke SK; Dillon MA
Kidney Int; 1999 Jan; 55(1):299-307. PubMed ID: 9893140
[TBL] [Abstract][Full Text] [Related]
14. Calcium, phosphate, and PTH levels in the hemodialysis population: a multicenter study.
Gallieni M; Cucciniello E; D'Amaro E; Fatuzzo P; Gaggiotti A; Maringhini S; Rotolo U; Brancaccio D;
J Nephrol; 2002; 15(2):165-70. PubMed ID: 12018633
[TBL] [Abstract][Full Text] [Related]
15. Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors.
Lajeunesse D; Delalandre A; Guggino SE
J Bone Miner Res; 2000 May; 15(5):894-901. PubMed ID: 10804019
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
17. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of hydrochlorothiazide on renal calcium and magnesium handling in postmenopausal women.
Stefíková K; Spustová V; Dzúrik R
Physiol Res; 1999; 48(4):327-30. PubMed ID: 10638687
[TBL] [Abstract][Full Text] [Related]
19. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women.
Rejnmark L; Vestergaard P; Pedersen AR; Heickendorff L; Andreasen F; Mosekilde L
Eur J Clin Invest; 2003 Jan; 33(1):41-50. PubMed ID: 12492451
[TBL] [Abstract][Full Text] [Related]
20. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
